Swiss Biotech Stock News

Naturenergie Holding AG recently reported past half-year results to June 30, 2026, with sales of €661.6 million versus €810.2 million a year earlier and net income of €45.5 million versus €69.7 million. The figures highlight how weaker top-line performance has filtered through to profits, raising questions about cost efficiency and business mix over the period. Next, we’ll examine how this contraction in sales and earnings shapes Naturenergie Holding’s investment narrative and future...

Ascom Holding came into this earnings day with a stock that had drifted, down around 11% over the past month and slightly weaker over the past week, while trading on a single digit P/E multiple. The H1 2026 numbers did not bring a flashy revenue surge, but they did show what matters most here. Profitability is quietly tightening, with basic earnings per share at CHF0.16 for the half and trailing net profit margin at 6.3%. The key point is that profit quality is improving while the market...

Autoneum Holding stock closed at CHF130.40 on 30 July, capping a strong run over the past month. Yet the real story in these H1 2026 results is not the share price. It is how a relatively low P/E of 12.3x sits beside a double digit trailing twelve month earnings per share of CHF10.60. For short term traders, the move has already happened. For longer term holders, the key question now is how to weigh that earnings power and modest 2.7% net profit margin against high debt and an uneven dividend...

Swissquote Group Holding (SWX:SQN) drew fresh attention after Goldman Sachs upgraded the stock to buy from neutral, citing stronger earnings potential in securities trading, foreign exchange and net interest income. See our latest analysis for Swissquote Group Holding. That upgrade comes after a sharp short term rebound in Swissquote Group Holding, with a 1 month share price return of 16.21% and a 3 year total shareholder return of 139.29%, although the 1 year total shareholder return is...

Sika (SWX:SIKA) drew fresh attention after its half year 2026 results, which showed broadly steady sales and earnings in Swiss francs, along with an upgrade to full year local currency sales guidance. See our latest analysis for Sika. The recent half year 2026 update seems to have shifted sentiment around Sika, with the stock showing a 7 day share price return of 13.86% and a 90 day share price return of 24.88%. However, the 1 year total shareholder return is down 6.31% and the 5 year total...

The European stock market has recently shown resilience, with the pan-European STOXX Europe 600 Index posting a modest gain amid robust corporate earnings and geopolitical tensions. As investors navigate these complex conditions, identifying undervalued stocks can offer potential opportunities for those seeking to capitalize on price discrepancies relative to fair value.

As European markets navigate a landscape marked by robust corporate earnings and geopolitical tensions, the pan-European STOXX Europe 600 Index recently posted gains, reflecting investor optimism amid higher oil prices and potential policy shifts. In this environment, growth companies with substantial insider ownership can be particularly appealing as they often signal confidence from those closest to the business, aligning well with market conditions that value stability and strategic...

Soft earnings didn't appear to concern V-ZUG Holding AG's ( VTX:VZUG ) shareholders over the last week. We did some...

Roche Holding (SWX:ROP) received FDA 510(k) clearance for its cobas BV/CV molecular diagnostic assay, expanding its sexual health testing portfolio in the United States. The assay is designed to support more accurate diagnosis of bacterial vaginosis and vulvovaginal candidiasis, two common women's health conditions that are often misdiagnosed. The EMA’s Committee for Medicinal Products for Human Use issued a positive opinion for Susvimo, a ranibizumab implant for neovascular age related...

Schindler Holding (SWX:SCHN) reaffirmed its 2026 earnings guidance and released half-year results, giving investors fresh detail on how Modernization, Service and New Installations are shaping the company’s revenue profile this year. See our latest analysis for Schindler Holding. The reaffirmed guidance and higher earnings come against a mixed share price picture for Schindler Holding, with the stock down 12.11% on a year-to-date share price return and the 1-year total shareholder return also...

Logitech International went into this print with the stock already grinding higher, up roughly 14% over three months and sitting at CHF87.82 at yesterday’s close. The headline is not the top line; the real story is profit power. Q1 FY2027 net income reached about US$235.7m with basic earnings per share at US$1.64 and trailing net profit margin at 16.3% compared with 13.8% a year earlier. The market now has to decide whether today’s move prices in that margin reset or fixates on the coming...

Investors came into SIG Group riding a strong three month run, only to see fresh H1 2026 numbers test that optimism. The stock closed at CHF15.33 on 28 July, with the market already pricing in a recovery story. The headline is that SIG Group moved back into the black at the half year, with basic earnings per share of €0.35 and net income of €134.1m, even as trailing twelve month figures remain loss making. The real question now is whether this step toward profitability is enough to justify...

UBS has just put fresh attention on capital markets and investment banking after reporting Q2 pre tax profits of US$3.6b, up 64% year on year, alongside a new US$3b share buyback. The CEO also called the recent AI pullback a healthy correction and pointed to strong M&A and IPO activity, even as geopolitical risks linger. For investors, that mix of solid earnings, active deal flow and an AI reset could be significant. This article walks through 3 stocks exposed to those same news drivers and...

Nestlé SA recently announced a plan to create Peranel, a 50:50 joint venture with Platinum Equity for its waters and premium beverages business, valuing the new company at about €4.90 billion and implying roughly €3.00 billion in cash proceeds for Nestlé when the deal closes, while also reporting half‑year 2026 sales of CHF43,109 million and net income of CHF3,472 million, both lower than a year earlier. The joint venture carves out more than 30 water and premium beverage brands into a...

As the European market navigates a landscape marked by robust corporate earnings and geopolitical tensions, indices like the STOXX Europe 600 have shown resilience with modest gains. In such an environment, growth companies with high insider ownership can be particularly appealing as they often indicate strong internal confidence and alignment of interests between management and shareholders.

Investors in SGS SA ( VTX:SGSN ) had a good week, as its shares rose 2.5% to close at CHF96.34 following the release of...

It's been a pretty great week for Schweiter Technologies AG ( VTX:SWTQ ) shareholders, with its shares surging 14% to...

Investors were disappointed by The Swatch Group AG's ( VTX:UHR ) latest earnings release. We did some further digging...

naturenergie holding entered this earnings release priced as a low multiple utility stock, trading on a trailing P/E of 6.8x and drifting over the last quarter with the share price down about 6.9% over 90 days. The market has treated it like a cheap stock with question marks over profit quality. The headline from this half year is pressure on earnings power. Trailing twelve month basic earnings per share of €4.92 sit alongside a discounted valuation and a net profit margin of 11.3%. That mix...

Why the new retina training centre matters for Alcon stock Alcon (SWX:ALC) is in focus after launching the Aravind Alcon Global Centre of Excellence for Vitreoretinal Surgery Training in Coimbatore, a new retina focused training hub within Aravind Eye Care System. See our latest analysis for Alcon. The retina training centre launch fits into a mixed year for Alcon, with the share price at CHF56.5, a small 1 month share price gain of 2.36% but a year to date share price decline of 11.08%,...

The market has treated Sulzer gently in recent weeks, with the stock up around 11.6% over the past month and closing at CHF152.3 on the day of the H1 2026 release. The headline from the numbers is not revenue growth; it is margin power. Sulzer lifted its reported EBITDA margin to about 15.5% in the first half while holding sales broadly steady. That mix of flattish top line and firmer profitability puts emotion to the test. Today’s price action looks like a debate over whether a margin driven...

Siegfried Holding (SWX:SFZN) has drawn investor attention after appointing Eduardo Montanha as Chief Operating Officer, consolidating oversight of Drug Substances and Drug Products into a single leadership role. See our latest analysis for Siegfried Holding. At a share price of CHF72.85, Siegfried Holding has seen a 1 month share price return of 4.07%, while the 1 year total shareholder return is down 22.43%. This suggests that recent momentum contrasts with weaker longer term results as...

Sika stock closed at CHF177.00 on 28 July, capping a solid three month run with a 90 day gain of about 23.8%. The market came into this earnings print with confidence already priced in. The headline from H1 is not revenue, which was broadly stable, but the grind in profitability. Net profit margin over the last year sits at 9.4%, lower than the prior 10.5%, even as Sika leans on its Fast Forward efficiency program. For investors, today is a sentiment check on that margin squeeze. The share...

LEM Holding stock went into today with a strong tailwind after a 54.3% gain over the past three months. The headline from this earnings release is a sharp rebound in profitability that clashes with any lingering turnaround doubts. Q1 2027 revenue came in at CHF 85.1m while net income reached CHF 9.1m. Basic earnings per share hit CHF 7.98. For a company often seen as a cyclical industrial tied to power electronics and automation demand, that size of earnings recovery is what moved the story,...